BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Dear Doctor Letter (Rote-Hand-Brief) on Viread® 204 mg film-coated tablet: incorrect dosage information in previous Summaries of Product Characteristics

Active substance: tenofovir disoproxil

The company Gilead Sciences GmbH is circulating information on incorrect dosage information in the Summaries of Product Characteristics of Viread 204 mg film-coated tablets.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 242KB, File is accessible

Use of cookies

Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy (only in German)

OK